Therefore, the study aimed to investigate differences in concentration of BDNF and proBDNF in patients with OSA and healthy participants, to evaluate their diurnal changes, and to assess their correlations with insomnia and depression symptoms that might contribute to specific OSA phenotypes. The gene discussed is BDNF; the disease is obstructive sleep apnea syndrome.